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Muscle Tissue Engineering Using Gingival Mesenchymal Stem Cells
Encapsulated in Alginate Hydrogels Containing Multiple Growth Factors
Abstract
Repair and regeneration of muscle tissue following traumatic injuries or muscle diseases often presents a
challenging clinical situation. If a significant amount of tissue is lost the native regenerative potential of
skeletal muscle will not be able to grow to fill the defect site completely. Dental-derived mesenchymal
stem cells (MSCs) in combination with appropriate scaffold material, present an advantageous alternative
therapeutic option for muscle tissue engineering in comparison to current treatment modalities available.
To date, there has been no report on application of gingival mesenchymal stem cells (GMSCs) in threedimensional scaffolds for muscle tissue engineering. The objectives of the current study were to develop
an injectable 3D RGD-coupled alginate scaffold with multiple growth factor delivery capacity for
encapsulating GMSCs, and to evaluate the capacity of encapsulated GMSCs to differentiate into
myogenic tissue in vitro and in vivo where encapsulated GMSCs were transplanted subcutaneously into
immunocompromised mice. The results demonstrate that after 4 weeks of differentiation in vitro, GMSCs
as well as the positive control human bone marrow mesenchymal stem cells (hBMMSCs) exhibited
muscle cell-like morphology with high levels of mRNA expression for gene markers related to muscle
regeneration (MyoD, Myf5, and MyoG) via qPCR measurement. Our quantitative PCR analyses revealed
that the stiffness of the RGD-coupled alginate regulates the myogenic differentiation of encapsulated
GMSCs. Histological and immunohistochemical/fluorescence staining for protein markers specific for
myogenic tissue confirmed muscle regeneration in subcutaneous transplantation in our in vivo animal
model. GMSCs showed significantly greater capacity for myogenic regeneration in comparison to
hBMMSCs (P<0.05). Altogether, our findings confirmed that GMSCs encapsulated in RGD-modified
alginate hydrogel with multiple growth factor delivery capacity is a promising candidate for muscle tissue
engineering.
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Abstract
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Repair and regeneration of muscle tissue following traumatic injuries or muscle diseases often
presents a challenging clinical situation. If a significant amount of tissue is lost the native
regenerative potential of skeletal muscle will not be able to grow to fill the defect site completely.
Dental-derived mesenchymal stem cells (MSCs) in combination with appropriate scaffold
material, present an advantageous alternative therapeutic option for muscle tissue engineering in
comparison to current treatment modalities available. To date, there has been no report on
application of gingival mesenchymal stem cells (GMSCs) in three-dimensional scaffolds for
muscle tissue engineering. The objectives of the current study were to develop an injectable 3D
RGD-coupled alginate scaffold with multiple growth factor delivery capacity for encapsulating
GMSCs, and to evaluate the capacity of encapsulated GMSCs to differentiate into myogenic tissue
in vitro and in vivo where encapsulated GMSCs were transplanted subcutaneously into
immunocompromised mice. The results demonstrate that after 4 weeks of differentiation in vitro,
GMSCs as well as the positive control human bone marrow mesenchymal stem cells (hBMMSCs)
exhibited muscle cell-like morphology with high levels of mRNA expression for gene markers
related to muscle regeneration (MyoD, Myf5, and MyoG) via qPCR measurement. Our
quantitative PCR analyses revealed that the stiffness of the RGD-coupled alginate regulates the
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myogenic differentiation of encapsulated GMSCs. Histological and immunohistochemical/
fluorescence staining for protein markers specific for myogenic tissue confirmed muscle
regeneration in subcutaneous transplantation in our in vivo animal model. GMSCs showed
significantly greater capacity for myogenic regeneration in comparison to hBMMSCs (P<0.05).
Altogether, our findings confirmed that GMSCs encapsulated in RGD-modified alginate hydrogel
with multiple growth factor delivery capacity is a promising candidate for muscle tissue
engineering.

Keywords
Tissue engineering; Muscle regeneration; Dental mesenchymal stem cells; RGD-coupled alginate
hydrogel
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Traumatic injuries, congenital defects and muscular diseases, such as muscular dystrophy,
usually cause significant muscle tissue loss necessitating application of regenerative
treatment modalities to rehabilitate the affected patients. However, larger defects are
challenging due to difficulties to find appropriate supply of muscle tissues.25, 45 An
advantageous and promising treatment modality for muscle tissue engineering is the
application of mesenchymal stem cells (MSCs). MSCs are multipotent cells that can
differentiate into multiple lineages, depending on the nature of the environmental signals
they receive. Specifically with regards to their capacity to form muscle, studies have shown
that direct implantation of MSCs functionally improves the capability of muscle
regeneration.2,4,9 However, a vital parameter for muscle tissue regeneration is the
identification of an optimal source of cell with suitable muscle differentiation capacity.
Studies have shown the presence of satellite cells (SCs) in mature muscles that are identified
to be committed to myogenic tissue regeneration.22,27 However, the main disadvantages
associated with the application of these SCs are the invasive isolation procedure and
difficulty in the purification process. In addition, the low expansion capacity of satellite cells
makes them a questionable cell source for repair of large muscle defects.15, 21, 22,27
Alternatively, it has been shown that MSCs can be identified and isolated from a wide range
of post-natal tissue types, including the craniofacial structures.10,17, 19, 43 One of the
attractive sources of MSCs in the craniofacial region is gingiva.53 Gingival mesenchymal
stem cells (GMSCs) are of particular interest as they are easily harvested in the oral
environment. GMSCs are obtained as discarded biological samples in dental clinics for
many common dental procedures.30, 31 Moreover, the donor site in the oral cavity tends to
heal faster than all other human dermal tissues, and completes healing without scarring. Our
previous studies and others have confirmed the multilineage differentiation capabilities of
these stem cells in vitro and in vivo.30–34, 53 Therefore, human GMSC-mediated tissue
regeneration can be considered as a promising cellular-based treatment for muscle tissue
engineering.
One of the challenges in the stem cell mediated tissue regeneration is development of a
suitable microenvironment for stem cells to proliferate and differentiate them to the desired
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lineage/phenotype. It is well known that scaffolds have important role in tissue
engineering.18, 39, 40, 49 It has been reported that stem cell-mediated tissue regeneration is
partially controlled by the recipient local microenvironment, including the presence of
growth factors, immune cells and cytokines.24, 11 To that end, exogenous growth factors
have been delivered along with stem cells to differentiate the stem cells to desired lineage/
phenotype. Several studies have demonstrated that the mechanical properties (e.g. elasticity)
of the scaffold control the survival and determine the fate of the stem cells.13,14,40 Therefore,
a scaffold with tunable physiochemical properties, to regulate the fate of encapsulated stem
cells, seems to be very important and practical in developing stem cell based therapies.

Author Manuscript

To develop a promising microenvironment for muscle regeneration based on GMSCs, we
sought to engineer a microenvironment with the physiochemical characteristics of the
extracellular micro-milieu. We utilized RGD-coupled alginate hydrogel to modify the niche
properties and to direct the cell phenotype through differentiation. Alginate microspheres
have been used extensively for controlled delivery of growth factors and have an excellent
track record for safety.3, 38, 39, 14 Presence of cell-binding peptides, such as RGD (arginineglycine-aspartic acid tripeptide), in the structure of the alginate scaffold could be
advantageous because these peptides mimic the cell-matrix interaction typical of the
ECM.26, 34 Studies have shown that alginate hydrogels have multiple growth factor delivery
capacity, which make the scaffold of choice for complex tissue regeneration purposes.8

Author Manuscript

Therefore, in the current study, we focus on the potential of the delivery of multiple growth
factors (a cocktail of Forskolin (FSK), MeBIO (6-Bromo-1-methylindirubin-3'-oxime), and
basic-FGF) to drive GMSCs differentiation into muscle tissue.1,7,16 Studies have shown that
FSK induces cell differentiation via direct activation of adenylate cyclase and the stimulation
of cyclic AMP (cAMP) production, promoting muscle regeneration in animal
models.1,167, 23, 42 Moreover, MeBIO (an analog of 6-bromoindirubin-30 - oxime) is a
specific inhibitor of glycogen synthase kinase-3 (GSK-3).47 It has been shown that this small
molecule can support self-renewal and pluripotency potential in human and mouse
embryonic stem cells (ESCs) leading to maintenance of stem cell properties.36 Furthermore,
it has been demonstrated that MeBIO has the ability to control the muscle regeneration and
proliferation of mammalian cardiomyocytes.47, 48 Basic fibroblast growth factor (bFGF)
plays an important role in the survival and differentiation of MSCs in muscle regeneration
and repair.43, 36

Author Manuscript

A literature search failed to reveal any reports evaluating the application of GMSCs
encapsulated in RGD-coupled alginate microspheres, with multiple growth factor delivery
capacity, in muscle repair and regeneration. Therefore, in the current study, we developed an
injectable and 3D RGD-coupled alginate hydrogel cell encapsulation architecture with
multiple growth factor delivery capability. Considering the fact that GMSCs can be easily
accessible from the oral cavity, and given the rapidity of healing without scar formation, they
can be considered ideal for stem cell banking purposes provided they show promise in MSCbased tissue regeneration. This approach was designed to optimize muscle regeneration for
potential application in the repair of the skeletal or cardiac muscle regeneration.
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Materials and methods
Animals
Female immunocompromised nude (Beige nu/nu XIDIII) mice were used in this study. All
the animal experiments were performed in accordance with IACUC-approved small animal
protocols at the University of Southern California.
Progenitor cell isolation, and culture
Human GMSCs were isolated and cultured according to previously published
procedures.51,52 Human bone marrow mesenchymal stem cells (BMMSCs), purchased from
Lonza (Gaithersburg, MD).

Author Manuscript

GMSCs, and hBMMSCs (as a positive control) were separately cultured in a regular culture
media containing alpha-MEM (Invitrogen) with 15% FBS, 2 mM L-glutamine (Invitrogen),
100 nM Dex, 100 µM ascorbic acid (Sigma), 2 mM sodium pyruvate (R&D Systems Inc,
Minneapolis, MN), 100 U/mL penicillin, and 100 µg/mL streptomycin (Sigma). Passage 4
cells were used in the experiments and hBMMSCs were used as the positive control group.
Flow cytometric analysis

Author Manuscript

Approximately 2× 105 of either GMSCs or hBMMSCs from passages 4 were incubated with
specific phycoerythrin conjugated mouse monoclonal antibodies for human CD34, and
CD45 (as negative hematopoietic stem cell marker), CD73, CD105, and CD146 (as positive
MSC marker) (BD Biosciences), or isotype-matched control immunoglobulin Gs (IgGs;
Southern Biotechnology Associates) and subjected to flow cytometric analysis using a
FACSCalibur with CellQuest software (BD Biosciences) according to methods previously
reported.34
Biomaterial fabrication and characterization
RGD-coupled alginate (NovaMatrix FMC Biopolymer, Norway) was used as the scaffold
material. Alginate was purified and partially oxidized (2%) to increase its degradability
according to published methods in the literature.30,31 The prepared alginate was
concentrated, freeze-dried under reduced pressure, and mixed with a cocktail containing 10
µM forskolin (FSK) (Sigma), 10 µM MeBIO (Santa Cruz Biotechnology), and 10 ng/ml
recombinant human bFGF (R&D Systems).

Author Manuscript

To study the effects of elasticity of the alginate hydrogel on myogenic differentiation
capacity of encapsulated GMSCs the elastic modulus (E) of alginate hydrogels in presence
of different concentrations of CaCl2 (10, 25, 50, 75, and 100 mM) was measured using an
Instron mechanical testing machine (Norwood, PA) at a compression rate of 0.5 mm.min−1
according to the methods already in literature.18
To characterize the release profile of all the components of the cocktail, the hydrogel
microspheres were loaded at the abovementioned concentrations and at each selected time
interval (1, 3, 5, 7, 10, 12, and 14 days), the amounts of medium were collected and
analyzed for released of FSK and MeBIO, using a UV spectrophotometer at 320 nm
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(Beckman, Brea, CA). Moreover, the release profile of bFGF was characterized using human
b-FGF Immunoassay kit (BioSource International Inc. Camerillo, CA).
Cell encapsulation and Live/dead staining
GMSCs and hBMMSCs (as a positive control) were encapsulated separately in alginate
loaded with cocktail of 10 µM forskolin (FSK), MeBIO (10 µM), and 10 ng/ml recombinant
human bFGF. Cells were encapsulated at a density of 2×106 cells/mL of alginate solution.
Microsphere formation was accomplished by adding the MSC-alginate mixture dropwise to
100 mM CaCl2 solution. The resulting microspheres were incubated at 37°C for 45 min to
complete cross-linking and then washed three times in non-supplemented DMEM. RGD
coupled alginate hydrogel without cells (and not loaded with cocktail) was used as the
negative control in this study.

Author Manuscript

Following 14 days of incubation in culture medium, the cell viability of the encapsulated
MSCs was measured as described according to methods in the literature32, 233 using calcein
AM to stain live cells and ethidium bromide homodimer-1 to stain dead cells (Invitrogen).
The percentage of live cells was measured using NIH ImageJ software (NIH, Bethesda,
MD).
Moreover, to evaluate stem cell viability in the alginate microspheres loaded with myogenic
differentiation cocktail, MTT assay was utilized according to previously published
protocols.34 The MTT absorbance was obtained at different time intervals (1, 7, and 14
days) and normalized to the absorbance of alginate containing the same type of stem cells
measured at day 1. For each experimental group tested five independent specimens were
analyzed at each time interval.

Author Manuscript

In vitro myogenic differentiation

Author Manuscript

To induce myogenic differentiation, encapsulated GMSCs and hBMMSCs (2×106 cells) in 1
mL alginate microspheres containing the growth factors cocktail were cultured in a medium
containing alpha- MEM with 15% FBS, 2 mM L-glutamine, 100 nM Dex, 100 µM ascorbic
acid, 2 mM sodium pyruvate (R&D Systems Inc), 100 U/mL penicillin, 100 µg/mL
streptomycin, and a cocktail of 10 µM forskolin (FSK), MeBIO, and 10 ng/ml recombinant
human bFGF. Cell free RGD-alginate microspheres without any growth factor were used as
the control group. Four weeks after induction, the samples were fixed with 4% PFA, and
paraffin sections were made. Sections were immunolabeled using antibodies against MF20
(R&D Systems Inc), Myf5, and MyoD (Santa Cruz Biotechnology Inc, Dallas, TX), at 4°C
overnight, detected using Alexa fluor conjugated secondary antibody (1:200 dilution;
Invitrogen), and counterstained with DAPI.
RNA isolation, reverse transcription and real time PCR
Following 2 weeks of myogenic differentiation RNA was extracted from the encapsulated
cells.32, 33 Data were analyzed by the 2−∆∆Ct method, with normalization to the Ct of the
housekeeping gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase). Primer
sequences are described in Table 1. Additionally, to study the effects of the elasticity of the
hydrogel biomaterial on the myogenic differentiation capacity of encapsulated cells; GMSCs
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were encapsulated in alginate hydrogels with different modulus of elasticity and after 2
weeks of myogenic differentiation, the myogenic genes expression levels were analyzed
using qPCR.
Western blot analysis
After two weeks of myogenic differentiation in vitro, Western blot analysis was performed
to analyze the differentiation of encapsulated MSCs. Primary antibody (mouse monoclonal
anti-MyoD antibody) was used at 1:500. Western blot analyses were carried out as
previously reported.33
In vivo model for muscle regeneration

Author Manuscript

All animals in our in vivo experiments were treated according to the approved Guidelines
and Regulations for the Use and Care of Animals (IACUC) at the University of Southern
California. 4 × 106 of GMSCs or hBMMSCs (passage 4) were encapsulated in RGDcoupled alginate microspheres loaded with myogenic differentiation cocktail and
approximately 500 µl (10 alginate microspheres) were implanted subcutaneously into the
dorsal surface of 5-month-old Beige nude mice (Harlan, Livermore, CA; N=4 for each
group). After 8 weeks of implantation the mice were sacrificed, and the microspheres and
the surrounding tissue were surgically removed and analyzed using histological and
immunohistochemical staining. Cell free RGD-alginate microspheres were used as the
negative control group.
Histological, Immunohistochemical and Immunofluorescence staining

Author Manuscript

Harvested specimens were fixed in 4% PFA solution, dehydrated in an ascending series of
ethanol, and embedded in paraffin. 6-µm sections were cut and glass slides were prepared.
Five randomly selected cross-sections from each group were stained with Hematoxylin &
Eosin (H&E).
Immunofluorescence staining was utilized and specimens were treated with 3% H2O2,
followed by a blocking buffer (1% BSA and 0.25% Triton X-100 in PBS). Then, sections
were incubated with anti-MyoD (Santa Cruz Biotechnology, Inc, 1:100 dilution), anti- Myf5
(Santa Cruz Biotechnology, Inc, 1:100 dilution) and detected using Alexa Fluor conjugated
secondary antibody (1:200 dilution; Invitrogen). The samples were then counterstained with
DAPI.

Author Manuscript

Moreover, to study the degree of local angiogenesis immunohistochemical analysis was
used. De-paraffinized sections were washed, and non-specific endogenous peroxidase
activity was quenched by immersing in 3% H2O2/methanol for 15 min.
Immunohistochemistry examination was performed on sections using anti-CD31 (Abcam,
1:200 dilution) and counterstaining with hematoxylin.
To identify the origin of the cells immunohistochemical staining was utilized. The retrieved
specimens were incubated with antibody directed against human mitochondria (mouse
antibody anti-human mitochondria; Chemicon, Billerica, MA) at 1:200 dilution and detected
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using the universal immunoperoxidase (HRP) ABC kit (Vector Laboratories). Subsequently,
sections were counterstained with hematoxylin.
Statistical Analysis
The Kruskal–Wallis rank sum test was utilized to analyze the data at a significance level of !
= 0.05. Also, two-tailed Student’s t-test and two-way ANOVA were utilized for comparisons
whenever needed. Quantitative data are expressed as mean ± standard deviation (SD).

Results

Author Manuscript

RGD coupled alginate microsphere fabrication and release profile characterization Our
results demonstrated that both GMSCs and hBMMSCs after two weeks of culturing in
myogenic condition media changed their morphology towards myogenic cells (Fig. 1a).
However, GMSCs exhibited morphological changes more rapidly and extensively in
comparison to hBMMSCs. In addition, the stem cells were expanded in vitro until passages
4 for further experiments. Our flow cytometric analysis revealed that the GMSCs as well as
hBMMSCs expressed specific MSC markers CD73, CD105, and CD146, but not the
hematopoietic lineage markers CD34 and CD45 (Fig. 1b) with similar expression profiles
confirming the stem cell properties of GMSCs. Moreover, the light microscopic imaging
confirmed that the fabricated alginate microspheres were of uniform size and showed even
cell distribution (Fig. 1c). Approximately, 10 microspheres were fabricated from each 1 mL
of alginate/MSC solution with average diameter of 650 micrometer for each microsphere
containing 105 loaded cells in each sphere. Our SEM analysis showed that the alginate
hydrogel had a porous morphology with encapsulated MSCs dispersed within the hydrogel
matrix (Fig. 1d).

Author Manuscript

In addition, live/dead assays exhibited high cell viability of encapsulated MSCs up to two
weeks of in vitro culturing (Fig. 2a). Additionally, our MTT assay confirmed that the
presence of the myogenic cocktail did not show any significant effects on MSC viability
(Fig. 2c), while MSCs encapsulated in RGD-containing alginate microspheres showed
significantly higher degrees of viability in comparison to MSCs encapsulated in non-RGD
coupled alginate microspheres (Fig. 2b). Moreover, MTT assay further confirmed the cell
viability data. The cytotoxicity of the alginate microencapsulation system loaded with
myogenic differentiation cocktail was quantitatively analyzed in vitro using MTT assay.
GMSCs- and hBMMSCs-alginate constructs showed high MTT absorbance, indicating high
metabolic activity and cell viability after up to 2 weeks of culturing in regular media (Fig.
2c).

Author Manuscript

Next, the possibility of utilization of alginate hydrogel as a scaffold with multiple growth
factor delivery capacity was analyzed and the release profile of FSK, MeBIO, and bFGF
from the RGD-coupled alginate scaffold was characterized for two weeks (Fig. 2d). The
cumulative release profile revealed the sustained release of all the components of the
differentiation cocktail for up to 14 days confirming the capability of our utilized cell
delivery system with multiple growth factor delivery capacity.
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Myogenic differentiation of GMSCs in vitro and the effects of hydrogel matrix elastic
modulus
Myogenic differentiation of encapsulated MSCs was confirmed after four weeks of
differentiation of encapsulated GMSCs and hBMMSCs in vitro by positive
immunofluorescence staining with antibodies against MF20 (also known as Myosin II),
MyoD, and Myf5. (Fig. 3a).29, 46 MyoD is one of the key regulators of muscle
differentiation.37 Myf5 is another protein member of this family It is a protein with a key
role in regulating muscle differentiation or myogenesis.37, 21 Without Myf5 and MyoD,
myogenic cells will fail to progress normally during the determination stage of
myogenesis.50, 51, 15, 46 Semi-quantitative analysis of the specimens confirmed that
engrafted GMSCs expressed higher amounts of myogenic related genes (MF20, Myf5, and
MyoD) than engrafted hBMMSCs (P-value < 0.05) (Fig. 3b).

Author Manuscript

In the next step, the molecular mechanism underlying the myogenic differentiation was
evaluated. Gene expression analyses were performed using several markers that are
associated with myogenic differentiation of MSCs, including MyoG, MyoD, and Myf5 (Fig.
4a). MyoG or myogenin is a member of the basic helix-loop-helix (bHLH) family of
transcription factors, which also includes MyoD and Myf5.49, 50

Author Manuscript

The expression levels of these myogenic genes were analyzed and compared via quantitative
PCR. Our results revealed that GMSCs as well as hBMMSCs expressed abundant MyoG,
MyoD, and Myf5 after cultured in myogenic cocktail (Fig. 4a). Specifically, RGD-coupled
alginate hydrogel markedly elevated myogenic gene expression when compared to non-RGD
alginate hydrogel (Fig. 4a). GMSCs showed significantly higher expression levels for all the
tested genes compared to hBMMSC (p<0.05). Moreover, encapsulation of GMSCs in
alginate hydrogel significantly enhanced the expression level of these myogenic genes
(P<0.05) in comparison to GMSCs cultured without any encapsulation (Figure 4b)
suggesting elasticity of alginate hydrogel may contribute to myogenesis of MSCs.
Additionally, our immunofluorescence staining (Figs. 5a and 5b) and PCR (Fig. 5c) analysis
confirmed that the modulus of RGD-coupled alginate hydrogel regulates the myogenic
differentiation of encapsulated MSCs. Our data obtained from quantitative PCR analysis
showed that MSC encapsulated in alginate hydrogel with intermediate modulus of elasticity
(10–16 kPa) exhibited the highest capacity for myogenic differentiation in comparison to
softer (<5kPa) or stiffer (>20kPa) hydrogels (Fig. 5c). Our findings are in good correlation
with data reported in the literature.10, 13,35

Author Manuscript

Furthermore, Western blot analysis showed increased expression levels of myogenesisrelated gene, MyoD, in specimens encapsulated in RGD-coupled alginate microspheres with
middle range elasticity containing myogenic differentiation cocktail (Fig. 5d). The results of
Western blot analysis correlated well with the data from the immunostaining and PCR
analyses.
Ectopic myogenic tissue regeneration in vivo
Encapsulated GMSCs in alginate microspheres loaded with myogenic differentiation
cocktail were subcutaneously implanted in immunocompromised mice. H&E staining

Ann Biomed Eng. Author manuscript; available in PMC 2017 June 01.

Ansari et al.

Page 9

Author Manuscript

showed the formation of small islands of muscle-like structures, while unresorbled alginate
hydrogel was still observed after 8 weeks of implantation (Fig. 6). Immunohistochemical
and immunofluorescent staining was used to detect newly formed tissue by gene expression
analysis. Immunofluorescence staining for MF20 and MyoD antigens after 8 weeks of
transplantation revealed extensive production and deposition of these markers within the
regenerated muscle tissues (Fig. 6a). Interestingly, engrafted GMSCs showed significantly
higher MF20 and MyoD expression levels in comparison to engrafted hBMMSCs (p < 0.05)
(Fig. 6b).
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In addition, the human origin of cellular components of the transplants was confirmed
through immunostaining with specific antibodies against human mitochondria (Fig. 7a).
Furthermore, immunohistochemical staining with CD-31 endothelial cell marker was
utilized to analyze the angiogenesis levels in the regenerated tissues. Our data showed that
implanted GMSCs in alginate hydrogel delivery system loaded with the myogenic
differentiating cocktail significantly increased the capillary density based on CD-31
endothelial cell marker staining and H & E staining in comparison to the control group
(Figs. 7a and 7b) confirming the contribution of engrafted GMSCs to enhanced local
vasculature. To examine the ability of implanted MSCs to form vascular networks in vivo,
microvessel density was determined, based on the H & E staining, by counting erythrocytecontaining luminal structures in the retrieved specimens. Our data (Fig. 7b) confirmed that
implanted GMSCs formed significantly higher number of perfused blood vessels in
comparison to hBMMSCs (P<0.05).

Discussion
Author Manuscript
Author Manuscript

Studies have exploited the potential of cell-based therapies to promote muscle regeneration.
It has been shown the possibility of application of stem cells from muscle tissues, satellite
cells or entire myofibres for muscle tissue engineering. However, none of these strategies
have shown promising results and low expansion capacity (low regenerative capacity) of
these stem cell sources have been reported.15, 21, 22,27 In addition, the isolation procedure for
these type of stem cells is invasive and they require a difficult purification procedure.22,27 It
has been confirmed that pluripotent embryonic stem cells (ESCs) have great potential for
cell-based therapies. However, their applications are limited due to ethical issues,
heterologous immuno-rejection possibility, and the risk of teratoma formation.41 As an
alternative to ESCs, induced pluripotent stem cells (iPSCs) have been successfully utilized
for muscle tissue engineering. GMSCs are easily accessible by harvesting from the oral
cavity or cells can often be obtained as discarded biological tissue samples. Therefore,
gingiva can be considered as an ideal source for stem cell banking purposes provided they
show promise in MSC-based tissue regeneration.41 A thorough review of the literature
search revealed no report on application of gingival mesenchymal stem cells for muscle
tissue engineering. Therefore, in the current study we demonstrate that GMSCs encapsulated
in an injectable and biodegradable RGD-modified alginate hydrogel can effectively be
differentiated into muscle tissue in vitro and in vivo in the presence of appropriate inductive
signals. Alginate hydrogel coupled with RGD tripeptide was utilized as the cell delivery
system and loaded with a myogenic differentiation cocktail containing FSK, MeBIO, and
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recombinant human bFGF to optimize the microenvironment for GMSCs to be differentiated
into muscle tissue.
Our in vitro analyses demonstrate that RGD coupled alginate hydrogel encapsulation system
supported the viability of GMSCs and their myogenic differentiation capacity. GMSCs
exhibited significantly higher levels of MyoG, MyoD, and Myf5 mRNA expression in
comparison to hBMMSCs as the gold standard of MSC therapy.
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In the current study, we utilized RGD-coupled alginate microspheres as a delivery vehicle
for GMSCs and we confirmed the important role of microenvironment of the viability and
myogenic differentiation of encapsulated GMSCs. It was revealed that the elasticity of the
alginate hydrogel controls the fate of the encapsulated GMSCs. Our biomechanical analysis
showed that GMSCs encapsulated in alginate hydrogel with intermediate modulus of
elasticity (10–16 kPa) exhibited the highest capacity for myogenic differentiation in
comparison to softer (<5kPa) or stiffer (>20kPa) hydrogels. Additionally, encapsulation of
GMSCs in alginate hydrogel in the presence of the myogenic differentiation cocktail (in
vitro) doubled the expression level of myogenic related genes (MyoG, MyoD, and Myf5) in
comparison to GMSCs that were not encapsulated in alginate.
Moreover, in our previous studies we have shown that alginate hydrogels possess a porous
microstructure.16 The presence of porosities in the structure of alginate hydrogel enables the
diffusion of oxygen, nutrients and growth factors (e.g. FSK, MeBIO, and recombinant
human bFGF). This porous microstructure in the presence of RGD tripeptides synergistically
facilitates GMSC adhesion and availability of oxygen, nutrients and desirable growth
factors. These properties in combination with optimized matrix elasticity make alginate
hydrogel a highly suitable scaffold biomaterial for muscle tissue engineering.
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Furthermore, histological analysis of regenerated tissues in our in vivo studies confirmed the
formation of muscle-like organizations. Interestingly, GMSCs showed greater capacity for
muscle tissue regenerating in comparison to hBMMSCs. In addition, the implanted GMSCs
in alginate hydrogel delivery system loaded with the myogenic differentiating cocktail
showed increased capillary density and improved neo-vascularization and local angiogenesis
in comparison to the control group (hBMMSCs). Taking into account the availability and the
high capacity for muscle regeneration of GMSCs, it can be concluded that GMSCs are a
unique and promising candidate for muscle (skeletal and cardiac) tissue engineering in the
presence of appropriate microenvironment containing the suitable inductive signals. It has to
be emphasized that GMSCs were not cultured in myogenic induction media prior to their
application in vivo studies. These findings of the current study confirm the important role of
the microenvironment, as well as the value of presenting inductive signals necessary to
support the viability and differentiation of MSCs along a desired phenotype. More
importantly, considering the neural crest origin of GMSCs they might be utilized as a unique
platform for functional regeneration of smooth muscles (e.g. cardiac regeneration) or tongue
muscle tissues.
Here, in a proof of concept study, we demonstrate the potential of GMSCs to be utilized in
repair/regeneration of muscular tissues when encapsulated in an appropriately designed
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delivery vehicle loaded with myogenic growth factors. Additionally, the GMSC/alginate
hydrogel construct can be considered a promising candidate for vascularized tissue
engineering. Considering the promising results of the current study it can be envisioned that
GMSCs might be promising alternative for cardiac tissue engineering or tongue muscle
repair and regeneration.
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FIGURE 1. Development of RGD-coupled alginate hydrogel microenvironment containing
myogenic cocktail for encapsulation of MSCs
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(a) Characterization and comparison of the cellular morphology of GMSCs and hBMMSCs
before and during myogenic differentiation. (b) Evaluation and quantification of the
percentage of cells that express stem cell surface markers (passage 4) through flow
cytometric analysis. (c) Bright field image of translucent alginate microspheres showing
their retained spherical shape with a uniform cell distribution (average microsphere diameter
650 micrometer). (d) SEM image of the alginate hydrogel-MSC construct showing
encapsulated MSCs within porous alginate hydrogel microspheres after two weeks of
culturing in regular media. NS=not significant.
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FIGURE 2. MSC viability and release profile characterization of the alginate
microencapsulation system

Author Manuscript

(a, b) Live/dead staining of the encapsulated MSCs in alginate microspheres after one day
and two weeks of culturing (scale bar = 200 mm). Viability of the encapsulated MSCs was
measured as a percentage of live cells in either RGD-coupled alginate or non-RGD coupled
alginate microspheres after two weeks of culturing in regular media. (c) 3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay of metabolic activity of
encapsulated MSCs. No significant difference was observed between GMSCs and
hBMMSCs at each time interval. Also, the myogenic cocktail had no adverse effects of the
metabolic activity of the encapsulated MSCs. (d) Characterization of the in vitro release
profile of different components of the myogenic differentiation cocktail form the alginate
hydrogel microspheres showing the multiple growth factor delivery capacity of the alginate
microencapsulation system. Sustained release of FSK, MeBIO, and b-FGF was observed
from alginate microsphere for up to 2 weeks. *p < 0.05.
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FIGURE 3. In vitro myogenic differentiation of GMSC
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(a) Immunofluorescence staining against MF20 (Myosin Heavy Chain), Myf5 (Myogenic
factor 5), and MyoD (myogenic differentiation protein) antibodies after four weeks of in
vitro culturing in myogenic differentiation. Both GMSCs and hBMMSCs positively
immunostained with antibodies against MF20, Myf5, and MyoD. Results confirmed that
both hBMMSCs and GMSCs were positively stained for myogenic markers (white arrows),
while the negative control (−), cell-free alginate hydrogel microspheres failed to express any
of these myogenic markers. (b) Analysis of the percentage of cells positive for anti-MF20,
Myf5, and MyoD antibodies, showing higher expression levels of myogenic markers in
GMSCs in comparison to hBMMSCs (positive control) and negative control groups. *p <
0.05.
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FIGURE 4. Molecular analysis of myogenic differentiation of MSCs in vitro
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(a) RT-PCR analysis demonstrate significantly greater expression level (in fold changes) of
MyoG, Myf5, and MyoD genes for encapsulated GMSCs after 4 weeks of culturing in
myogenic differentiation media in vitro in comparison to hBMMSCs. The obtained data
were normalized by the Ct of the housekeeping gene GAPDH and expressed relative to the
expression level for the same gene at day 1. (b) The expression level of MyoG and MyoD
for encapsulated hBMMSCs and GMSCs in alginate hydrogel in comparison to scaffold-free
MSC cultures after two weeks of myogenic differentiation in vitro containing the myogenic
cocktail. Data confirmed the important role of the microenvironment and the presence of an
encapsulating scaffolds, as the encapsulated MSC expressed greater levels (p<0.05) of
expressions for examined myogenic genes in comparison to scaffold free MSC groups. *P
<0.05, **P<0.01.
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FIGURE 5. Fate determination and myogenic differentiation of MSCs encapsulated in RGDcoupled alginate hydrogel microspheres
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(a) Immunofluorescence detection of MyoD protein localized to the GMSCs encapsulated in
alginate microspheres with different modulus of elasticity after 4 weeks of culturing in
myogenic differentiation media (counterstained with DAPI). (b) Semi-quantitative analysis
of the percentage of cells positive for anti-MyoD antibodies via immunofluorescence
staining images in panel a. (c) MyoD gene expression evaluation via RT-PCR for GMSCs
encapsulated in RGD-coupled alginate hydrogel with different elastic moduli after 2 weeks
of culturing in myogenic differentiation media. (d) Western blot analysis presented changes
in the expression levels of regulators of myogenesis of GMSCs. The expression level of
MyoD gene is elevated in the encapsulated GMSCs in RGD containing alginate
microspheres with intermediate modulus of elasticity, while GMSCs encapsulated in
alginate hydrogels with higher or lower elastic modulus showed decreased levels of MyoD
gene expression conforming the important role of the mechanical properties of the matrix in
fate determination of the encapsulated MSCs. *P <0.05, **P<0.01.
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FIGURE 6. In vivo myogenesis of encapsulated GMSCs after subcutaneous transplantation

(a) GMSCs or hBMMSCs as the control group encapsulated in alginate hydrogel containing
myogenic cocktail were subcutaneously transplantation into immunocompromised mice and
myogenic tissue formation was analyzed after 8 weeks. Histological evaluation by
hematoxylin and eosine staining (top panel) confirmed partial islands of muscle regeneration
with typical myogenic morphology. Extensive positive staining in immunofluorescence
analysis against MF20 (middle panel) and MyoD (lower panel) antibodies further confirmed
myogenic differentiation of GMSC. The negative control (−) was cell-free alginate hydrogel
scaffold failed to exhibit any positive staining or myogenic tissue regeneration. (b) Semiquantitative analysis of the percentage of cells positive for anti-MF20 and MyoD antibodies
via immunofluorescence staining images. *p < 0.05. Alg= unresorbed alginate hydrogel.
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FIGURE 7. The origin of the implanted MSCs and their contribution to vascularization in vivo
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(a) The human origin of the engrafted GMSCs and hBMMSCs was confirmed by
immunohistochemical staining with an antibody specific for human mitochondria (white
arrows) (upper panel). Endothelial cell marker was identified by immunohistochemistry
using anti- CD31 antibody (middle panel). Histological evaluation by hematoxylin and
eosine staining (top panel) (yellow arrows) (lower panel). (b) Semi quantitative analysis of
microvessel density based on panel c data. *p < 0.05.
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Oligonucleotide primers used in RT-PCR analysis.
Gene

Sequence

Amplification
(bp)

MyoD

5" -GGGAAGAGTGCGGCGGTGTCGAG-3" (forward)
5"-TCCGAGAAGGGTGCTGCGTGGAA-3" (reverse)

448

MYF5 (Myogenic factor 5)

5" -TTC TCC CCA TCC CTC TCG CT -3" (forward)
5" -AGC CTG GTT GAC CTT CTTCAG-3" (reverse)

285

MyoG (Myogenin, MYF4)

5" -CAG CTC CCT CAA CCA GGA -3" (forward)
5" -GCT GTG AGA GCT GCA TTC G-3" (reverse)

245

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)

5’-AGCCGCATCTTCTTTTGCGTC-3’ (forward)
5’-TCATATTTGGCAGGTTTTT CT-3’(reverse)

418
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